Riskpilot← Back to searchSign inGet full accessFint Och Rent ILEM AB
ABActiveOrg 5591955702Scheelevägen 7Retail sale of pharmaceutical products · NACE 4773Est. 20191 employees
Revenue 2025
SEK 408K
-16% vs 2024
EBITDA margin
-18.1%
-132% vs 2024
Equity ratio
77.2%
Financial strength
Net profit 2025
SEK -89K
-139% vs 2024
| Revenue | SEK 408K | -16% |
| EBITDA | SEK -74K | -132% |
| Net profit | SEK -89K | -139% |
| Total assets | SEK 257K | -22% |
| Equity | SEK 199K | -31% |
| Employees | 1 | — |
Legal name
Fint Och Rent ILEM AB
Org number
5591955702
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
19 februari 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Städa och flytt.
Address
Scheelevägen 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 8 560 | 8 250 | 4 322 | 486 | 408 |
| Staff expenses | — | — | −446 | −255 | −251 |
| EBITDA | 325 | 1 437 | −1 672 | 231 | −74 |
| Depreciation & amort. | −86 | −86 | — | — | −15 |
| EBIT | 239 | 1 351 | −1 672 | 231 | −89 |
| Net financials | −42 | −10 | 0 | −1 | 0 |
| Profit before tax | 197 | 1 341 | −1 672 | 230 | −89 |
| Tax | −45 | −278 | — | — | — |
| Net profit | 152 | 1 063 | −1 672 | 230 | −89 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 496 | 2 900 | 138 | 331 | 257 |
| Equity | 1 036 | 2 099 | 57 | 287 | 199 |
| Long-term debt | 500 | 0 | — | — | — |
| Short-term debt | 960 | 801 | 81 | 43 | 59 |
| Total debt | 1 460 | 801 | 81 | 43 | 59 |
EBITDA margin
-18.1%
This company
15.8%
Market median
-215% vs market
20212025
Equity ratio
77.2%
This company
38.2%
Market median
+102% vs market
20212025
Return on equity
-44.7%
This company
18.4%
Market median
-343% vs market
20212025
Net profit margin
-21.8%
This company
8.1%
Market median
-369% vs market
20212025
Asset turnover
1.59×
This company
1.12×
Market median
+42% vs market
20212025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-11-01 – 2022-10-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-10-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KK Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (3) | ||
TM Chief Auditor | Chief Auditor | 2020 – 2024 |
MK Chief Auditor | Chief Auditor | 2022 – 2022 |
KE Chief Auditor | Chief Auditor | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
| Former (2) | ||
| Board of Directors | 2020 – 2024 | |
| Deputy Board Member | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Fint Och Rent ILEM AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tony Mikael Salonen | Chief Auditor | 0 companies |
| Kamal Kassem | Chief Executive Officer | 0 companies |
| Maria Kersti Theander | Chief Auditor | 0 companies |
| Karl Erik Sebastian Schelander | Chief Auditor | 0 companies |
| Maggie Aila Malke | Board of Directors | 0 companies |
| Mithal Kassem | Deputy Board Member | 0 companies |
| Jacob Jack Malke | Deputy Board Member | 0 companies |